Utah Medical Products UTMD Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 57.9%+0.8pp | 57.1%0.0pp | 57.1%-0.2pp | 57.3%-1.0pp | 58.4%-0.7pp | |
| Operating margin | 28.8%-0.8pp | 29.6%-1.2pp | 30.8%-1.7pp | 32.5%-0.2pp | 32.8%-0.5pp | |
| Net margin | 28.9%-0.4pp | 29.3%-0.8pp | 30.1%-2.3pp | 32.3%-0.7pp | 33%-0.9pp | |
| EBITDA margin | 36.6%-0.7pp | 37.3%-1.1pp | 38.3%-1.6pp | 40%0.0pp | 40%-0.1pp | |
| Free cash flow margin | 34.7%-2.5pp | 37.2%+1.2pp | 35.9%+0.4pp | 35.5%+0.8pp | 34.7%-1.0pp | |
| Returns | ||||||
| Return on equity | 9.1%-0.4pp | 9.5%-0.1pp | 9.6%-0.8pp | 10.4%-0.2pp | 10.6%-0.7pp | |
| Return on assets | 8.8%-0.4pp | 9.2%0.0pp | 9.2%-0.8pp | 10%0.0pp | 10%-0.7pp | |
| Efficiency | ||||||
| Asset turnover | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | 0.3×0.0× | |
| Inventory turnover | 1.8×-0.2× | 2×0.0× | 1.9×0.0× | 1.9×+0.1× | 1.8×0.0× | |
| Liquidity | ||||||
| Current ratio | 28.6×-9.0× | 37.6×+5.6× | 32.1×-9.8× | 41.9×+19.6× | 22.3×-3.3× | |
| Quick ratio | 26.2×-8.4× | 34.6×+5.2× | 29.4×-8.9× | 38.2×+17.9× | 20.3×-3.0× | |
| Cash ratio | 24.9×-8.1× | 33×+5.0× | 28×-8.5× | 36.5×+17.2× | 19.3×-2.8× | |
| Leverage | ||||||
| Debt-to-equity | 0×— | —— | —— | —— | —— | |
| Debt-to-assets | 0×— | —— | —— | —— | —— | |
| Net debt / EBITDA | -6.4×— | —— | —— | —— | —— | |
| Per Share | ||||||
| Book value per share | $37.79+2.7% | $36.81-0.2% | $36.87+1.8% | $36.21+2.4% | $35.36+5.5% | |
| Valuation | ||||||
| Market capitalization | $219.63M+26.4% | $179.28M-11.2% | $201.86M+11.5% | $180.99M-1.6% | $183.91M-11.8% | |
| Enterprise value | $132.44M+42.5% | —— | —— | —— | —— | |
| Price / earnings | 20.3×+6.4× | 15.9×-1.5× | 17.4×+3.0× | 14.4×+0.2× | 14.2×-0.8× | |
| Price / sales | 5.9×+1.4× | 4.7×-0.6× | 5.2×+0.6× | 4.7×0.0× | 4.7×-0.4× | |
| Price / book | 1.9×+0.4× | 1.5×-0.2× | 1.7×+0.2× | 1.5×0.0× | 1.6×-0.2× | |
| EV / EBITDA | 10.5×+4.0× | —— | —— | —— | —— | |
| EV / sales | 3.9×+1.2× | —— | —— | —— | —— | |
| Free cash flow yield | 5.6%-1.9pp | 8%+1.1pp | 6.9%-0.7pp | 7.6%+0.2pp | 7.4%+0.4pp | |
| Earnings yield | 4.7%-2.2pp | 6.3%+0.5pp | 5.8%-1.2pp | 6.9%-0.1pp | 7%+0.4pp | |
| Dividend yield | 1.7%-0.5pp | 2.2%+0.2pp | 2%-0.3pp | 2.3%0.0pp | 2.3%+0.2pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Utah Medical Products's profit margins?
- Utah Medical Products (UTMD) runs a 57.9% gross margin and a 28.8% operating margin, with a 28.9% net margin.
- Where do Utah Medical Products's ratios come from?
- Every ratio is computed from Utah Medical Products's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
